# Insulin Lispro

## Humalog KwikPen 100U/mL 3mL

| TAH Drug Code      | [IHUMX](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IHUMX)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Diabetes mellitus                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Dosing             | Diabetes mellitus， type 1: Initial The total daily doses (TDD): SUBQ: ~0.4 to 0.5 units/kg/day. Usual TDD maintenance range: SUBQ: 0.4 to 1 units/kg/day in divided doses. Diabetes mellitus， type 2: SUBQ: 4 to 6 units or 10% of the basal insulin dose.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | Hypersensitivity to insulin lispro or any component of the formulation; during episodes of hypoglycemia.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Adverse Effects    | >10%: Endocrine & metabolic: Severe hypoglycemia (<=14%) Immunologic: Antibody development (19% to 33%) Local: Infusion-site reaction (3% to 38%; includes infusion-site pain [16%]) Nervous system: Headache， pain Respiratory: Cough， flu-like symptoms， nasopharyngitis (5% to 15%)， pharyngitis， rhinitis 1% to 10%: Dermatologic: Pruritus (<=1%) Gastrointestinal: Abdominal pain， diarrhea， nausea Local: Injection-site reaction (3% to 6%， may be secondary to excipient; including bruising at injection site， erythema at injection site， inflammation at injection site， injection-site pruritus， pain at injection site， rash at injection site) Nervous system: Asthenia Neuromuscular & skeletal: Myalgia (may be secondary to excipient) Respiratory: Bronchitis， upper respiratory tract infection (1% to 7%) <1%: Cardiovascular: Peripheral edema Hypersensitivity: Hypersensitivity reaction Local: Hypertrophy at injection site， lipoatrophy at injection site Frequency not defined: Endocrine & metabolic: Hypokalemia， weight gain |
| Pregnancy          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| More Info          | [UpToDate](https://www.uptodate.com/contents/insulin-lispro-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |

